ADGM ▲ +2.2% - Adagio Medical Holdings, Inc. $ADGM Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix Adagio Medical rose 2.2% following news that the first patient has been treated in an IDE (Investigational Device Exemption) study evaluating its next-generation vCLAS™ Ultra System for treating ventricular tachycardia at Banner – University of Arizona Medical Center Phoenix. The initiation of patient enrollment in this clinical trial represents a key milestone for the company's cardiac ablation technology. 16-SEP-2026 08:00 AM ET